Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€120.10

€120.10

-0.870%
-1.05
-0.870%
€165.00
 
10:34 / Tradegate WKN: 886455 / Symbol: AZNCF / Name: AstraZeneca / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

AstraZeneca plc Stock

AstraZeneca plc shows a slight decrease today, losing -€1.050 (-0.870%) compared to yesterday.
The community is currently still undecided about AstraZeneca plc with 1 Buy predictions and 0 Sell predictions.
With a target price of 165 € there is a positive potential of 37.39% for AstraZeneca plc compared to the current price of 120.1 €.
Our community identified positive and negative aspects for AstraZeneca plc stock for the coming years. 2 users see the criterium "Non-cyclic/Cyclic" as a plus for the AstraZeneca plc stock. On the other hand our users think that "General Risks" could be a problem in the future.

Pros and Cons of AstraZeneca plc in the next few years

Pros
?
S********** s********
?
B****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of AstraZeneca plc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
AstraZeneca plc -0.870% -1.982% 1.466% -0.656% -0.859% 45.701% 61.104%
GSK plc -0.160% -1.560% -1.019% 21.147% 15.943% 27.306% 9.169%
Elanco Animal Health Inc. 1.520% -0.955% -3.714% 65.451% 7.396% -48.520% -
Pfizer Inc. 0.000% -1.541% -0.390% -32.336% -2.107% -14.862% -26.861%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-04

Based on the financial statements of AstraZeneca, a pharmaceutical company with the US symbol AZNCF, the company appears to have experienced some growth and stability in recent years. However, there are still a few areas of concern among some positive trends. To fully understand the financial health of AstraZeneca, it is essential to conduct a detailed analysis of the company's financial statements, focusing on key financial metrics, pros, and cons.

Revenue growth: AstraZeneca's total revenue has been consistently growing in recent years, as indicated by the increase from 26.62 billion EUR in 2020 to 37.42 billion EUR in 2021 and 44.35 billion USD in 2022. This demonstrates a positive trend in sales and business performance.

Stable net income: Compared to 2021, AstraZeneca registered a significant improvement in net income, which stabilized at 3.29 billion USD in 2022. The consistent net income indicates that the company can meet its financial obligations, invest in new opportunities, and maintain profitability.

Comments

Sell AstraZeneca plc
Show more

Prediction Buy
Perf. (%) 28.85%
Target price 62.350
Change
Ends at 10.03.22

Considering AZN's strong performance and the estimated growth of the sector due to COVID-19, we issue a buy recommendation.
Show more

Buy AstraZeneca plc
Show more